These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33504067)

  • 1. Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals.
    Younes S; Al-Jighefee H; Shurrab F; Al-Sadeq DW; Younes N; Dargham SR; Al-Dewik N; Qotba H; Syed M; Alnuaimi A; Yassine HM; Tang P; Abu-Raddad LJ; Nasrallah GK
    Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33504067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.
    Ismail A; Shurrab FM; Al-Jighefee HT; Al-Sadeq DW; Qotba H; Al-Shaar IA; Yassine HM; Abu-Raddad LJ; Nasrallah GK
    Front Biosci (Landmark Ed); 2021 Jul; 26(7):198-206. PubMed ID: 34340267
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees.
    Younes N; Al-Sadeq DW; Shurrab FM; Zedan HT; Abou-Saleh H; Abo-Halawa BY; AlHamaydeh FM; Elsharafi AE; Daas HI; Thomas S; Aboalmaaly S; Al Farsi A; Al-Buainain R; Ataelmannan S; Paul J; Al Saadi AS; Yassine HM; Majdalawieh AF; Ismail A; Abu-Raddad LJ; Nasrallah GK
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
    Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
    Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.
    Shurrab FM; Younes N; Al-Sadeq DW; Liu N; Qotba H; Abu-Raddad LJ; Nasrallah GK
    Int J Infect Dis; 2022 May; 118():132-137. PubMed ID: 35231609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies.
    Lokida D; Karyana M; Kosasih H; Mardian Y; Sugiyono RI; Arlinda D; Lukman N; Salim G; Butar Butar DP; Naysilla AM; Irmansyah
    Heliyon; 2022 Dec; 8(12):e12614. PubMed ID: 36575657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
    Nicholson S; Karapanagiotidis T; Khvorov A; Douros C; Mordant F; Bond K; Druce J; Williamson DA; Purcell D; Lewin SR; Sullivan S; Subbarao K; Catton M
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab239. PubMed ID: 34258311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.
    Garritsen A; Scholzen A; van den Nieuwenhof DWA; Smits APF; Datema ES; van Galen LS; Kouwijzer MLCE
    Infect Dis (Lond); 2021 Jul; 53(7):498-512. PubMed ID: 33684020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of SARS-CoV-2 IgG assays in India.
    Chaudhuri S; Thiruvengadam R; Chattopadhyay S; Mehdi F; Kshetrapal P; Shrivastava T; Desiraju BK; Batra G; Kang G; Bhatnagar S;
    J Clin Virol; 2020 Oct; 131():104609. PubMed ID: 32866811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
    Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
    Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers.
    Aguilar R; Li X; Crowell CS; Burrell T; Vidal M; Rubio R; Jiménez A; Hernández-Luis P; Hofmann D; Mijočević H; Jeske S; Christa C; D'Ippolito E; Lingor P; Knolle PA; Roggendorf H; Priller A; Yazici S; Carolis C; Mayor A; Schreiner P; Poppert H; Beyer H; Schambeck SE; Izquierdo L; Tortajada M; Angulo A; Soutschek E; Engel P; Garcia-Basteiro A; Busch DH; Moncunill G; Protzer U; Dobaño C; Gerhard M
    Microbiol Spectr; 2023 Feb; 11(1):e0316522. PubMed ID: 36622140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the
    Pieri M; Infantino M; Manfredi M; Nuccetelli M; Grossi V; Lari B; Tomassetti F; Sarubbi S; Russo E; Amedei A; Benucci M; Casprini P; Stacchini L; Castilletti C; Bernardini S
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):74. PubMed ID: 35227017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
    Takahashi M; Saito K; Ai T; Nojiri S; Khasawneh A; Paran FJ; Horiuchi Y; Takei S; Yamamoto T; Wakita M; Hiki M; Miida T; Naito T; Takahashi K; Tabe Y
    PLoS One; 2023; 18(1):e0279779. PubMed ID: 36693058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration.
    Simon G; Favresse J; Gillot C; Closset M; Catry É; Dogné JM; Douxfils J; Wieërs G; Bayart JL
    Clin Chem Lab Med; 2023 Sep; 61(10):1875-1885. PubMed ID: 37078220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
    Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
    J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Serology: Utility and Limits of Different Antigen-Based Tests through the Evaluation and the Comparison of Four Commercial Tests.
    Gdoura M; Halouani H; Sahli D; Mrad M; Chamsa W; Mabrouk M; Hogga N; Ben-Salem K; Triki H
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera.
    Ahn MJ; Kang JA; Hong SM; Lee KS; Kim DH; Song D; Jeong DG
    Biochem Biophys Res Commun; 2023 Feb; 646():8-18. PubMed ID: 36696754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.